| 2022 | | Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational study | 박준성 |
| 2021 | | Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia | 강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁 |
| 1997 | | Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. | 김효철 |
| 2018 | | Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy | 강석윤 |
| 2016 | | Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study | 박준성, 정성현 |
| 2014 | | Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors. | 박준성, 정성현 |
| 2018 | | Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) | 이현우 |
| 2021 | | Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study | 이현우 |
| 2020 | | Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial | 강석윤 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호 |
| 2019 | | EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment | 강석윤 |
| 2007 | | Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. | 강석윤, 김효철, 박준성, 이현우, 최진혁 |
| 2022 | | Erratum: Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin | 강석윤, 김철호, 김태환, 신승수, 신유섭, 안미선, 오영택, 이현우, 장전엽, 최용원, 최진혁, 허재성 |
| 2020 | | Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931) | 안미선 |
| 2014 | | Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation. | 김세란, 박주한, 박준성 |
| 2022 | | Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer | 강석윤 |
| 2002 | | Expression of multidrug resistance-associated protein1,P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. | 김명욱, 김효철, 이기범, 임호영, 조용관, 주희재, 최진혁 |
| 2001 | | Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. | 김명욱, 김현수, 김효철, 남동기, 이기범, 임호영, 조용관, 주희재, 최진혁 |
| 2020 | | Extranodal NK/T cell lymphoma | 정성현 |
| 1995 | | Factor VNew Brunswick: Ala221-to-Val substitution results in reduced cofactor activity. | 김효철 |
